Mr. Jeremy Sobotta reports

PERIMETER MEDICAL IMAGING AI ANNOUNCES INITIATION OF ADDITIONAL CLINICAL TRIAL SITE AT BAPTIST MD ANDERSON CANCER CENTER IN JACKSONVILLE, FL

Perimeter Medical Imaging AI Inc. has initiated an additional clinical trial site at Baptist MD Anderson Cancer Center in Jacksonville, Fla., under the direction of Dr. Laila Samiian, MD, FACS.

Laila Samiian, MD, FACS, Director, Breast Program at Baptist MD Anderson Cancer Center, stated, "We are excited to become the newest active site with three investigators anticipated to participate in this clinical study to assess if the Perimeter B-Series with artificial intelligence demonstrates an improvement over the current standard of care. Combining optical coherence tomography with deep learning algorithms could assist us, as surgeons, to better identify regions of interest supporting 'real-time' decisions on margin status in the OR - potentially setting a new standard for specimen imaging technology during breast conservation surgery."

Jeremy Sobotta, Perimeter's Chief Executive Officer stated, "Our ongoing pivotal clinical trial evaluating our breakthrough-device-designated Perimeter B-Series OCT technology with proprietary, next-gen 'ImgAssist' artificial intelligence continues to advance. All initially planned sites have been activated, and we recently received FDA approval to expand the number of institutions to further support patient enrollment. We are excited to initiate Baptist MD Anderson Cancer Center with the goal of further accelerating study completion."

About the Perimeter B-Series OCT with ImgAssist AI Pivotal Trial

Led by Principal Investigator, Dr. Alastair Thompson at the Baylor College of Medicine in Houston, TX, patient enrollment is ongoing in Perimeter's multi-center, randomized two-arm pivotal clinical trial evaluating the investigational Perimeter B-Series OCT combined with its proprietary ImgAssist AI software in approximately 330 patients, with study completion anticipated by the end of 2023.

About Perimeter Medical Imaging AI, Inc.

Based in Toronto, Canada and Dallas, Texas, Perimeter Medical Imaging AI (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) is a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address areas of high unmet medical need. Available across the U.S., our FDA-cleared Perimeter S-Series OCT system provides real-time, cross-sectional visualization of excised tissues at the cellular level. The breakthrough-device-designated investigational Perimeter B-Series OCT with ImgAssist AI represents our next-generation artificial intelligence technology that is currently being evaluated in a pivotal clinical trial, with support from a grant of up to US$7.4 million awarded by the Cancer Prevention and Research Institute of Texas. The company's ticker symbol "PINK" is a reference to the pink ribbons used during Breast Cancer Awareness Month.

We seek Safe Harbor.